BSEBoard Meeting6d ago · 27 Aug 2026, 06:39 pm
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026 ,inter alia, to consider and approve Please refer to the intimation ....
Gujarat Themis Biosyn Ltd · 506879
✦ AI SummaryFundraise
Gujarat Themis Biosyn Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026, inter alia, to consider and approve raising funds through issue of equity shares and/or convertible warrants through preferential issue on a private placement basis.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Intimation for Intimation Of The Board Meeting
Attachments (1)
📄pdf
Download →
238b45d6-121a-4b1d-ae10-f5ca1d5f41de.pdf
View document text
GUJARAT THEMIS
BIOSYN LIMITED
CIN: L24230GJ1981PLC004878
REGD. OFFICE &FACTORY: 69/C GIDC INDUSTRIAL ESTATE,
VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA
TEL: 0260-2430027 / 2400639
E-mail:hrm@gtbl.in.net
GTBL/BSE/NSE/2026-27/55 27th August 2026
Listing Department Department of Corporate Services
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Dalal Street
Bandra Kurla Complex Mumbai 400001
Bandra East, Mumbai 400051
Symbol: GUJTHEM Scrip Code: 506879
Dear Sir/Madam,
Sub.: Intimation for Board Meeting pursuant to the SEBI (Listing Obligations and Disclosure
Requirements) Regulations 2015.
Dear Sir/Madam
Pursuant to provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of
the Company is scheduled on 1st September 2026, inter alia, to approve raising funds through issue
of equity shares and/or convertible warrants through preferential issue on a private placement
basis, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure
Requirements) Regulations, 2018 and the Companies Act, 2013, subject to necessary approvals
including approval of the Shareholders of the Company and stock exchanges.
Further, in terms of the "Code of Conduct for Monitoring and Prevention of Insider Trading”
adopted by the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the
Trading Window for dealing in the equity shares of the Company shall remain closed for all the
concerned Designated Persons and their immediate relatives till the end of 48 hours after the
outcome of the meeting is announced.
Thanking you
Yours faithfully
For Gujarat Themis Biosyn Limited
Vineet Gawankar
Company Secretary & Compliance Officer
MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104
Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019; E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in